Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 492 participants.
Also called NCT04734353
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 492 participants
- Registry
-
NCT04734353
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04734353. Randomized; no masking; primary purpose treatment. Start 2020-01-15 (actual); primary completion 2021-06-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)
- Acronym
- E-5TION
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Prasugrel 5mg
- Intervention (Drug)
- Ticagrelor 60mg
- Lead sponsor
- Gyeongsang National University Hospital
- Collaborator
- U&I Corporation
Record details
- Record id
cardio:ct-nct04734353- Content hash
8c00e57cc7ffc53049fccfa00eb5088be37c70a6f541d70359bab9638f8e476f